Advertisement

Topics

Ohr Pharmaceutical to Announce Third Quarter 2016 Financial Results on August 9

20:00 EDT 1 Aug 2016 | Globe Newswire

NEW YORK, Aug. 02, 2016 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), an ophthalmology research and development company, today announced that it will report financial results for the third quarter ended June 30, 2016 after the market close on Tuesday, August 9, 2016.  The Company will also hold a live investor conference call and webcast at 5:00pm Eastern Time.

Conference Call & Webcast
Tuesday, August 9th at 5:00pm Eastern Time
 
Domestic:877-407-0789
International:201-689-8562
Conference ID:13642605
Webcast:http://public.viavid.com/index.php?id=120651
 
Replays – Available through August 16, 2016
Domestic:877-870-5176
International:858-384-5517
Conference ID:13642605


About Ohr Pharmaceutical, Inc.
Ohr Pharmaceutical, Inc. (Nasdaq:OHRP) is an ophthalmology research and development company. The company's lead drug candidate, Squalamine lactate ophthalmic solution, 0.2% (also known as OHR-102), is currently being studied using an eye drop formulation in a Phase 3 clinical program for the treatment of the wet form of age-related macular degeneration.  In addition, Ohr has a sustained release micro fabricated micro-particle ocular drug delivery platform with several preclinical drug product candidates in development for glaucoma, steroid-induced glaucoma, ocular allergies, and protein drug delivery.  Additional information on the company may be found at www.ohrpharmaceutical.com.

Contact:
Ohr Pharmaceutical Inc.
Investor Relations		
888-388-2327			
ir@ohrpharmaceutical.com

LifeSci Advisors, LLC
Michael Wood
646-597-6983
mwood@lifesciadvisors.com

Primary Logo

NEXT ARTICLE

More From BioPortfolio on "Ohr Pharmaceutical to Announce Third Quarter 2016 Financial Results on August 9"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Ophthalmology
Ophthalmology is the branch of medicine that is devoted to the study and treatment of eye diseases. As well as mild visual defects correctable by lenses, ophthalmology is concerned with glaucoma, uveitis and other serious conditions affecting the eye, ...

Drug Delivery
<!--LGfEGNT2Lhm-->Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals.  <!--LGfEGNT2Lhm-->Drug delivery technologies are <!--LGfEGNT2Lhm-->patent pr...